State Farm LifePath 2010 A Legacy
Three State Farm Plaza N-1 Bloomington IL 61791-0001
Map
Phone: 800-447-4930
| Category: | Target-Date 2000-2014 | | Fund Family: | State Farm | | Net Assets: | 191.03M | | Year-to-Date Return: | -18.72% | | Yield: | 3.01% | | Morningstar Rating: |  | | Fund Inception Date: | 09-May-03 |
|
Dagmar Nikles
Lead Manager since
30-Jun-05 | | | Nikles is an employee of Barclays and BGI and is primarily responsible for the day-to-day management of the LifePath Funds. She has been a member of the asset allocation portfolio management team since July 2003. Prior to joining BGI, she received her Financial Risk Manager Certification and prior to that, she was an assistant portfolio manager and analyst at Zurich Scudder Investment from 2000 to 2002. |
| Min Initial Investment: | $250 | | Min Initial Investment, IRA: | $250 | | Min Initial Investment, AIP: | $50 | | Min Subsequent Investment: | $50 | | Min Subsequent Investment, IRA: | $50 | | Min Subsequent Investment, AIP: | $50 |
|
| |
| The investment seeks to maximize assets for retirement or other purposes. The fund invests all of assets in a separate master portfolio of the master fund that has a substantially identical investment objective as the LifePath fund. Each master portfolio, in turn, invests in a combination of stock, bond and money market funds. As of December 31, 2007, it intends to hold about 43% of assets in the underlying stock funds, 56% of assets in the underlying bond funds and the rest of assets in the underlying money market fund. |
| Last Dividend
(31-Dec-07):
| 0.31 | | Last Cap Gain
(31-Dec-07):
| 0.33 | | Annual Holdings Turnover
| 7.00% | | Average for Category:
| 38.45% |
|
| Expense | SATAX | Category
Avg | | Total Expense Ratio: | 1.17%
| 0.72% | | Max 12b1 Fee: | 0.25%
| N/A | | Max Front End Sales Load: | 3.00%
| 5.04% | | Max Deferred Sales Load: | 0.00%
| 2.58% | | 3 Yr Expense Projection*: |
$691 | $899 | | 5 Yr Expense Projection*: |
$976 | $1,534 | | 10 Yr Expense Projection*: |
$1,788 | $2,808 |
|
|
2.63% Nasdaq 0.00%
Profile
